This opportunity is no longer accepting applications.
grant PAR-22-149

NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)

This grant opportunity from the National Eye Institute (NEI) supports early-stage clinical trials focused on vision disorders. These trials, considered to have significant risk, often fall into Phase I or II categories and require strong oversight and safety monitoring. The research should aim to assess methods for screening, diagnosing, preventing, or treating eye-related conditions.

The NEI uses U01 cooperative agreement awards to support investigator-initiated early-stage clinical trials that are greater than minimal risk and typically are Phase I or II trials. The risk level of the U01 trial requires appropriate performance oversight and safety monitoring. For purposes of…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Eye Institute
Program: SBIR

Dates

Opportunity Released: April 12, 2022
Open for Submission: April 12, 2022
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.